An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Investigator: Bincy Abraham

Study Coordinator: Melissa Whipple

Status: Enrolling

ClinicalTrials.gov Number: NCT05369832

Phone: 713.441.3247

Protocol Number: PRO00036895

Description

The purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active ulcerative colitis (UC) in clinical practice.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials